We have collected information about Scherer Drug Delivery for you. Follow the links to find out details on Scherer Drug Delivery.
https://www.catalent.com/oral-dose/softgel-technologies/rp-scherer-softgel-technology/
As the innovator of softgel technologies, Catalent RP Scherer softgel brings more than 80 years of development expertise and manufacturing experience to the full spectrum of lipid-based drug delivery. Softgel technology is proven to enhance bioavailability for poorly soluble molecules.
https://www.dragonroids.com/rp-scherer-drug-delivery/
R.P. Scherer’s proprietary technologies — including soft gelatin capsules, Zydis, and topical Microsponge and Polytrap microparticles — deliver a variety of benefits, including improving a drug’s solubility, stability, efficacy and patient compliance, as well as …
https://www.ondrugdelivery.com/author/manuel-scherer/
Manuel Scherer is a Business Development Manager for SABIC’s specialties healthcare segment in Europe He leads a team of healthcare business professionals, focused on multinational healthcare OEMs, working across the value chain to drive innovations in medical device platforms.
https://vimeo.com/67726477
Jun 05, 2013 · As innovators of softgel technology, Catalent RP Scherer softgel brings more than 75 years of development expertise and manufacturing experience to the full spectrum of drug delivery. Softgel drug delivery …Author: Catalent
https://drug-dev.com/eyesol-a-novel-topical-ocular-drug-delivery-system-for-poorly-soluble-drugs/
Dr. Dieter Scherer joined Novaliq in April 2009 as its Chief Business Officer. His 20 years of experience covers the gamut from business development and licensing to product development in the field of drug delivery.
https://japan.catalent.com/index.php/news-events/news/catalent-presents-drug-delivery-strategies-at-7th-annual-improving-solubility-conference-in-philadelphia
Catalent RP Scherer softgel, embodies more than 75 years of development expertise and manufacturing experience applicable to the full spectrum of drug delivery. Softgel is the drug delivery solution of choice that solves complex formulation, solubility, bioavailability, and development challenges, bringing more molecules to market faster.
https://en.wikipedia.org/wiki/Zydis
History. Zydis technology was developed by R.P. Scherer Corporation (currently owned by Catalent Pharma Solutions) in 1986. The technology's first commercial application was in August, 1993, when a new dosage form of Pepcidine from Merck & Co. was launched in Sweden.In November 1993 Imodium Lingual from Janssen Pharmaceutica was released in Germany with Zydis technology.
https://www.catalent.com/about-us/overview/
In 1955, R P Scherer’s experimental machine was placed in the Smithsonian Institution in Washington D.C. The process of production of softgel capsules is still widely used and since its introduction, R P Scherer, now a part of Catalent, has become the world’s leader in softgel innovation and largest global manufacturer of softgels.
http://ijpsr.com/?action=download_pdf&postid=21754
Pulsatile Drug Delivery Systems: 1-3 A Pulsatile drug delivery system delivers drug in rapid and burst manner within a short time period immediately after a programmable lag phase. There are many situations where drug is needed to be released immediately (after bursting the delaying film coat) at specific site. These situations,
Searching for Scherer Drug Delivery?
You can just click the links above. The data is collected for you.
